Concepedia

Elise A. Chong

EA

52

Publications

4.5K

Citations

24

H-Index

2005

Active since

Affiliations

University of Pennsylvania(Current)

UPMC Hillman Cancer Center

Hospital of the University of Pennsylvania

Memorial Sloan Kettering Cancer Center

Novartis (Switzerland)

Elise A. Chong is an author at University of Pennsylvania specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2005–2025

52

Publications

52

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Stephen J. Schuster, Jakub Svoboda, Elise A. Chong et al. · New England Journal of Medicine · 2017 · 1.8K citations · Full text

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 316 citations · Full text

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Melody Smith, Anqi Dai, Guido Ghilardi et al. · Nature Medicine · 2022 · 285 citations · Full text

, , +10

Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma

Stephen J. Schuster, Sattva S. Neelapu, Barry L. Gause et al. · Journal of Clinical Oncology · 2011 · 241 citations · Full text

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Guido Ghilardi, Joseph A. Fraietta, James N. Gerson et al. · Nature Medicine · 2024 · 231 citations

, , +10

Rows per page

1–5 of 52